* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Reference:
[1] Journal of Organic Chemistry, 1993, vol. 58, # 8, p. 2313 - 2316
[2] Synthetic Communications, 2007, vol. 37, # 20, p. 3493 - 3499
2
[ 5267-64-1 ]
[ 28920-43-6 ]
[ 130406-30-3 ]
Reference:
[1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 404 - 414
[2] Journal of the American Chemical Society, 2006, vol. 128, # 12, p. 4023 - 4034
3
[ 1235475-85-0 ]
[ 130406-30-3 ]
Reference:
[1] Letters in Organic Chemistry, 2010, vol. 7, # 2, p. 159 - 162
Fmoc-D-α-amino-4-(protected)-aminobutyric acid[ No CAS ]
1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid [(7R,10R)-10-(2-amino-ethyl)-7-benzyl-9,12,16-trioxo-7,8,9,10,11,12,13,14,15,16-decahydro-6H-5-oxa-8,11,15-triaza-benzocyclotetradecen-2-yl]-amide[ No CAS ]
Fmoc-L-α-amino-4-(protected)-aminobutyric acid[ No CAS ]
1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid [(7R,10S)-10-(2-amino-ethyl)-7-benzyl-9,12,16-trioxo-7,8,9,10,11,12,13,14,15,16-decahydro-6H-5-oxa-8,11,15-triaza-benzocyclotetradecen-2-yl]-amide[ No CAS ]